Skip to content
Home/Companies/Biotech/Synklino

Synklino

Biotech·Denmark·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Synklino?

Synklino is a Danish Biotech company, currently owned by Eifo since 2020.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Eifo
Investor
Eifo
EIFO (direct equity) · 1992 · VC

Key facts

HQDenmark
SectorBiotech
StatusActive

More from EIFO (direct equity)

Other portfolio companies in the same fund.

Adcendo
Adcendo
Active
BiotechDenmark· 2026
Bactolife
Active
BiotechDenmark· 2026
Serpier
Active
AdTechDenmark· 2026
Six Robotics
Active
Aerospace & DefenceDenmark· 2026
Streamwerk
Active
SoftwareDenmark· 2026
Lotus Microsystems
Active
Deep TechDenmark· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Synklino?

Synklino is currently owned by Eifo, through EIFO (direct equity), since 2020.

When did Eifo acquire Synklino?

Eifo acquired Synklino in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue